封面
市場調查報告書
商品編碼
2078918

神經影像市場:按技術、應用、最終用戶和地區分類

Neuroimaging Market, By Technology, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2026年神經影像市場規模估計為449億美元,預計2033年將達到684.1億美元。預計2026年至2033年,該市場將以6.2%的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 449億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 6.20% 2033年市場規模預測: 684.1億美元

神經影像學是醫學影像學的一個分支,它能夠視覺化大腦的結構和功能。它為我們深入了解各種疾病和障礙背後的神經過程和異常提供了寶貴的視角。這項技術徹底革新了神經科學領域,並且大大增進了我們對人腦的理解。

市場動態:

神經影像市場受多種因素驅動。神經系統疾病盛行率的不斷上升導致對精準診斷工具的需求日益成長,從而推動了神經影像成像技術的應用。此外,磁振造影(MRI)、正子斷層掃描(PET)和電腦斷層掃描(CT)等影像診斷技術的進步顯著提高了腦部影像的解析度和準確性。

然而,該市場也面臨諸多限制因素。神經影像設備的高成本及其相關的維護和營運費用,阻礙了其普及,尤其是在發展中地區。此外,某些影像技術的安全隱患,例如電腦斷層掃描中的電離輻射暴露,也對市場成長構成挑戰。

儘管如此,神經影像市場仍蘊藏著許多機會。加大研發投入,開發功能性磁振造影(fMRI)和擴散張量成像(DTI)等先進影像技術,預計將推動市場成長。此外,對個人化醫療的日益重視以及人工智慧(AI)在神經影像領域的融合,也為市場擴張開闢了新的途徑。

本研究的主要特點:

  • 本研究揭示了各個細分市場的潛在商機,並為該市場說明了一個具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究基於以下參數,對神經影像市場的主要參與者進行了概況分析:公司概況、產品系列、關鍵亮點、財務績效和策略。本研究涵蓋的主要參與者包括:通用電氣公司、西門子醫療股份公司、飛利浦醫療保健、東芝醫療系統株式會社、日立醫療保健、佳能醫療系統株式會社、邁瑞醫療國際有限公司、Esaote SpA、NeuroLogica Corporation、NeuroVive Pharmaceutical AG、Brainlab AG、Akili Solutions、NeuroVista、東軟醫療系統、Positron Corporation、島津公司和Trifoil Imaging。
  • 透過利用本報告中提出的見解,各公司的行銷負責人和經營團隊將能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
  • 這份神經影像市場報告的目標受群眾外包括產業內的各種相關人員,例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 透過分析神經影像市場時所使用的各種策略矩陣,相關人員將能夠做出更順利的決策。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
  • 市場限制因素
  • 市場機遇
  • 主要亮點
  • 監管趨勢
  • 近期趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 併購和合作

第4章:神經影像市場:依技術分類,2021-2033年

  • 磁振造影(MRI)
  • 電腦斷層掃描(CT)
  • 正子斷層掃描(PET)
  • 單光子發射電腦斷層掃描(SPECT)
  • 功能性磁振造影(fMRI)
  • 彌散張量成像(DTI)
  • 腦磁圖(MEG)
  • 腦電圖(EEG)
  • 其他

第5章:神經影像市場:依應用領域分類,2021-2033年

  • 神經病變
  • 精神疾病
  • 創傷性腦損傷(TBI)

第6章:神經影像市場:依最終使用者分類,2021-2033年

  • 醫院和診所
  • 診斷中心
  • 研究機構
  • 門診手術中心
  • 其他

第7章 神經影像市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第8章 競爭情勢

  • 公司簡介
    • GE Healthcare
    • Siemens Healthineers
    • Philips Healthcare
    • Toshiba Medical Systems Corporation
    • Hitachi Healthcare
    • Canon Medical Systems Corporation
    • Mindray Medical International Limited
    • Esaote SpA
    • NeuroLogica Corporation
    • NeuroVive Pharmaceutical AG
    • Brainlab AG
    • Akili Interactive Labs Inc.
    • Brainomix Ltd.
    • Imaging Science International
    • Mevis Medical Solutions
    • NeuroVista
    • Neusoft Medical Systems
    • Positron Corporation
    • Shimadzu Corporation
    • Trifoil Imaging.
  • 分析師意見

第9章

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI6384

Neuroimaging Market is estimated to be valued at USD 44.90 Bn in 2026 and is expected to reach USD 68.41 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.2% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 44.90 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 6.20% 2033 Value Projection: USD 68.41 Bn

Neuroimaging is a branch of medical imaging that allows for the visualization of the structure and function of the brain. It provides valuable insights into the neurological processes and abnormalities that underline various diseases and disorders. This technology has revolutionized the field of neuroscience and has contributed significantly to understanding of the human brain.

Market Dynamics:

The neuroimaging market is driven by several factors. Growing prevalence of neurological disorders has increased the demand for accurate diagnostic tools, thus leading to the adoption of neuroimaging technologies. Moreover, the advancements in imaging technology, such as magnetic resonance imaging (MRI), positron emission tomography (PET), and computed tomography (CT), have significantly improved the resolution and accuracy of brain imaging.

However, the market also faces certain restraints. The high cost of neuroimaging equipment and the associated maintenance and operational costs limit its accessibility, especially in developing regions. Concerns regarding the safety of certain imaging modalities, such as ionizing radiation exposure in CT scans, pose challenges for market growth.

Nevertheless, the neuroimaging market presents several opportunities. The increasing investment in research and development (R&D) activities to develop advanced imaging techniques, such as functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI), is expected to drive market growth. Rising focus on personalized medicine and the integration of artificial intelligence (AI) in neuroimaging offer new avenues for market expansion.

Key features of the study:

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the neuroimaging market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies. Key companies covered as a part of this study include General Electric Company, Siemens Healthineers AG, and Philips Healthcare, Toshiba Medical Systems Corporation, Hitachi Healthcare, Canon Medical Systems Corporation, Mindray Medical International Limited, Esaote SpA, NeuroLogica Corporation, NeuroVive Pharmaceutical AG, Brainlab AG, Akili Interactive Labs Inc., Brainomix Ltd., Imaging Science International, Mevis Medical Solutions, NeuroVista, Neusoft Medical Systems, Positron Corporation, Shimadzu Corporation, and Trifoil Imaging..
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The neuroimaging market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the neuroimaging market

Detailed Segmentation:

  • Neuroimaging Market, By Technology (Revenue, USD Bn, 2021 - 2033)
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • Positron Emission Tomography (PET)
  • Single Photon Emission Computed Tomography (SPECT)
  • Functional Magnetic Resonance Imaging (fMRI)
  • Diffusion Tensor Imaging (DTI)
  • Magnetoencephalography (MEG)
  • Electroencephalography (EEG)
  • Others
  • Neuroimaging Market, By Application (Revenue, USD Bn, 2021 - 2033)
  • Neurological Disorders
    • Alzheimers Disease
    • Parkinsons Disease
    • Multiple Sclerosis
    • Epilepsy
    • Stroke
    • Others
  • Psychiatric Disorders
    • Schizophrenia
    • Bipolar Disorder
    • Depression
    • Anxiety Disorders
    • Others
  • Traumatic Brain Injury (TBI)
    • Brain Tumors
    • Others
  • Neuroimaging Market, By End User (Revenue, USD Bn, 2021 - 2033)
  • Hospitals and Clinics
  • Diagnostic Centers
  • Research Institutes
  • Ambulatory Surgical Centers
  • Others
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Top Companies in Neuroimaging Market
  • GE Healthcare
  • Siemens Healthineers
  • Philips Healthcare
  • Toshiba Medical Systems Corporation
  • Hitachi Healthcare
  • Canon Medical Systems Corporation
  • Mindray Medical International Limited
  • Esaote SpA
  • NeuroLogica Corporation
  • NeuroVive Pharmaceutical AG
  • Brainlab AG
  • Akili Interactive Labs Inc.
  • Brainomix Ltd.
  • Imaging Science International
  • Mevis Medical Solutions
  • NeuroVista
  • Neusoft Medical Systems
  • Positron Corporation
  • Shimadzu Corporation
  • Trifoil Imaging

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Technology
    • Market Snippet, By Application
    • Market Snippet, By End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Market Restraints
  • Market Opportunities
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • Product Launches/Approvals
  • PEST Analysis
  • PORTERs Analysis
  • Mergers, Acquisitions, and Collaborations

4. Neuroimaging Market, By Technology, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Magnetic Resonance Imaging (MRI)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Computed Tomography (CT)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Positron Emission Tomography (PET)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Single Photon Emission Computed Tomography (SPECT)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Functional Magnetic Resonance Imaging (fMRI)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Diffusion Tensor Imaging (DTI)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Magnetoencephalography (MEG)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Electroencephalography (EEG)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

5. Neuroimaging Market, By Application, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Neurological Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
      • Alzheimers Disease
      • Parkinsons Disease
      • Multiple Sclerosis
      • Epilepsy
      • Stroke
      • Others
  • Psychiatric Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
      • Schizophrenia
      • Bipolar Disorder
      • Depression
      • Anxiety Disorders
      • Others
  • Traumatic Brain Injury (TBI)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
      • Brain Tumors
      • Others

6. Neuroimaging Market, By End User, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2022 - 2033
    • Segment Trends
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Diagnostic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Bn)

7. Neuroimaging Market, By Region, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Region, 2022 -2033
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Bn)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive Landscape

  • Company Profile
    • GE Healthcare
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Siemens Healthineers
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Philips Healthcare
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Toshiba Medical Systems Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Hitachi Healthcare
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Canon Medical Systems Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Mindray Medical International Limited
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Esaote SpA
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • NeuroLogica Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • NeuroVive Pharmaceutical AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Brainlab AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Akili Interactive Labs Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Brainomix Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Imaging Science International
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Mevis Medical Solutions
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • NeuroVista
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Neusoft Medical Systems
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Positron Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Shimadzu Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Trifoil Imaging.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
  • Analyst Views

9. Section

  • References
  • Research Methodology
  • About us